Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
-
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines Conference
-
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
-
Passage Bio to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Passage Bio to Present at Chardan’s 6th Annual Genetic Medicines Conference
-
Passage Bio to Participate in Upcoming Investor Conferences
-
Passage Bio to Participate in Upcoming Investor Conferences
-
Passage Bio to Participate in Upcoming October Conferences
-
Passage Bio to Participate in Upcoming October Conferences
-
Passage Bio to Participate in Upcoming April Investor Conferences
-
Passage Bio to Participate in Upcoming April Investor Conferences
-
Passage Bio Inc. (PASG) PT Raised to $45 at Chardan Capital Markets
-
Passage Bio (PASG) Prices 7M Share Common Offering at $22/Sh
-
Passage Bio Announces Pricing of Public Offering
-
Passage Bio Announces Pricing of Public Offering
-
Passage Bio (PASG) Announces Launch of 7M Share Proposed Public Offering
-
Passage Bio Announces Launch of Proposed Public Offering
-
Passage Bio Announces Launch of Proposed Public Offering
-
Passage Bio to Participate in Upcoming October Investor Conferences
-
Passage Bio to Participate in Upcoming October Investor Conferences
-
Passage Bio Announces Exercise of Underwriters’ Option to Purchase Additional Shares
-
Passage Bio Announces Exercise of Underwriters’ Option to Purchase Additional Shares
-
Passage Bio (PASG) IPO Opens 24% Higher
-
Passage Bio, Inc. (PASG) Prices 12M Share IPO at $18/Sh
-
Passage Bio Announces Pricing of Initial Public Offering
